FTSJD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.903000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.762600E-01
Normal-vs-Stage2
3.866000E-01
Normal-vs-Stage3
2.615800E-01
Normal-vs-Stage4
3.809400E-01
Stage1-vs-Stage2
8.637400E-01
Stage1-vs-Stage3
1.434790E-01
Stage1-vs-Stage4
4.435600E-01
Stage2-vs-Stage3
1.353370E-01
Stage2-vs-Stage4
4.955400E-01
Stage3-vs-Stage4
1.116400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.950800E-01
Normal-vs-AfricanAmerican
3.777600E-01
Normal-vs-Asian
8.697900E-02
Caucasian-vs-AfricanAmerican
7.978000E-01
Caucasian-vs-Asian
5.639800E-01
AfricanAmerican-vs-Asian
8.841200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.928400E-01
Normal-vs-Female
3.896200E-01
Male-vs-Female
9.243200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.178800E-01
Normal-vs-Age(41-60Yrs)
4.274800E-01
Normal-vs-Age(61-80Yrs)
3.742000E-01
Normal-vs-Age(81-100Yrs)
3.779200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.266600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.994000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.633000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.907980E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.202800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.835400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.402800E-01
Normal-vs-Daily Drinker
3.404200E-01
Normal-vs-Weekly Drinker
1.529220E-01
Normal-vs-Occasional Drinker
4.220800E-01
Normal-vs-Social Drinker
4.948600E-01
Non Drinker-vs-Daily Drinker
9.834800E-01
Non Drinker-vs-Weekly Drinker
1.866760E-01
Non Drinker-vs-Occasional Drinker
2.461000E-01
Non Drinker-vs-Social Drinker
5.762200E-02
Daily Drinker-vs-Weekly Drinker
2.279000E-01
Daily Drinker-vs-Occasional Drinker
2.873800E-01
Daily Drinker-vs-Social Drinker
8.278300E-02
Weekly Drinker-vs-Occasional Drinker
8.030600E-01
Weekly Drinker-vs-Social Drinker
7.137200E-01
Occasional Drinker-vs-Social Drinker
4.937000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.486600E-01
Normal-vs-Grade 2
6.741000E-01
Normal-vs-Grade 3
6.410800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.090400E-01
Grade 1-vs-Grade 3
7.989200E-01
Grade 1-vs-Grade 4
3.486600E-01
Grade 2-vs-Grade 3
4.283200E-01
Grade 2-vs-Grade 4
6.741000E-01
Grade 3-vs-Grade 4
6.410800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.753200E-01
Normal-vs-NonDiabetic
3.844400E-01
Diabetic-vs-NonDiabetic
8.028000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.621800E-01
Normal-vs-NoPancreatitis
3.803800E-01
Pancreatitis-vs-NoPancreatitis
7.352000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.918800E-01
Normal-vs-N1
3.843000E-01
N0-vs-N1
8.955400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.053200E-01
Normal-vs-TP53-NonMutant
5.059400E-01
TP53-Mutant-vs-TP53-NonMutant
8.279600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
